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Protein interactionType 1 secretion systems (T1SS) are wide-spread among Gram-negative bacteria. An important example is the
secretion of the hemolytic toxin HlyA from uropathogenic strains. Secretion is achieved in a single step directly
from the cytosol to the extracellular space. The translocation machinery is composed of three indispensable
membrane proteins, two in the inner membrane, and the third in the outer membrane. The inner membrane
proteins belong to the ABC transporter and membrane fusion protein families (MFPs), respectively, while the
outer membrane component is a porin-like protein. Assembly of the three proteins is triggered by accumulation
of the transport substrate (HlyA) in the cytoplasm, to form a continuous channel from the inner membrane,
bridging the periplasm and ﬁnally to the exterior. Interestingly, the majority of substrates of T1SS contain all
the information necessary for targeting the polypeptide to the translocation channel — a speciﬁc sequence at
the extreme C-terminus. Here, we summarize our current knowledge of regulation, channel assembly,
translocation of substrates, and in the case of the HlyA toxin, its interaction with host membranes. We try to
provide a complete picture of structure function of the components of the translocation channel and their
interactionwith the substrate. Althoughwewill place the emphasis on the paradigmof Type 1 secretion systems,
the hemolysin A secretion machinery from E. coli, we also cover as completely as possible current knowledge of
other examples of these fascinating translocation systems. This article is part of a Special Issue entitled: Protein
trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
In Gram-negative bacteria, proteins or other biomolecules targeted
to the extracellular space have to pass two hydrophobic barriers, the
inner and outer membrane (IM or OM), before they reach their ﬁnal
destination. Obviously, different solutions to the same fundamental
problem have emerged during evolution. These include the Type 1 to
6 secretion systems and it is likely that further systemswill be identiﬁed
in the future [1,2]. In principle, one can classify these secretion
processes based on the underlying overall mechanism of transport.
One class, including Type 1, Type 3 and Type 4 (conjugation-like
systems) catalyze one-step secretion direct to the medium, while
Types 2, 4 and 5 (auto transporters) use a two-step procedure to shuttle
the transport substrate to the exterior. Type 4 secretion systems
interestingly possess a dual role. Depending on the substrate, either a
one-stepmechanism or a sequential, two-stepmechanism is employed,
while the exact mechanism of Type 6 secretion is currently under
investigation [1]. No matter which particular solution is employed and
which system is being considered, all secretion machineries deal with
the same fundamental challenge — how to translocate amphiphilic orin trafﬁcking and secretion in
albey.
+49 211 81 15310.
ights reserved.hydrophilic molecules, which are often of impressive size, across two
hydrophobic barriers.2. Introduction to Type 1 secretion systems (T1SS)
Type 1 secretion systems (T1SS), sometimes referred to as ABC-
dependent [3], are widespread in pathogenic Gram-negative bacteria
such as Escherichia coli, Vibrio cholerae or Bordetella pertussis. The ﬁrst
protein secretion process discovered in bacteria was the hemolysin A
(HlyA) T1SS which is found in certain uropathogenic E. coli strains
[4–6]. This secretionmachinery is composed of ‘only’ three components.
Two proteins, an ATP-binding cassette (ABC) transporter and a
membrane fusion protein (MFP) reside in the IM, while the third
component is localized in the OM. In the case of the HlyA T1SS these
three players are HlyB (ABC transporter), HlyD (MFP) and TolC (OMP).
Further details on the genetic organization and architecture of the
secretion machinery are given in the subsequent sections below.
Substrates of T1SS have an impressive range in size, from small
proteins such as the 20kDa iron scavengerHasA from Serratiamarcescens
[7], the 110kDa HlyA hemolysin, up to amolecular weight of 900kDa for
LapA, a large adhesion protein from Pseudomonas ﬂuorescens [8].
In the following sectionswe shall focus primarily on theHlyA T1SS of
E. coli, which serves as the paradigm for the family. Wherever
appropriate we shall also provide the reader with results derived from
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T1SS.
Before startingwith adetailed description of T1SS and inparticular the
HlyA system, we would like to propose a clear deﬁnition of T1SS.
Eventually this might be used by other researchers to reduce the
confusion that exists in the ﬁeld. In our opinion, a T1SS is deﬁned by
three membrane proteins, an ABC transporter, an MFP and an outer
membrane protein that act in concert to secrete a substrate in one step
across two membranes. The substrate is characterized by the presence
of a non-cleaved, C-terminal secretion sequence. Consequently,
bacteriocin exporting systems that are widespread in Gram-positive
bacteria are by deﬁnition not T1SS, since the outer-membrane
component and the C-terminal secretion signal are absent. Similarly, the
deﬁnition excludes the 10 kDa E. coli colicin V, which targets the ABC
transporter using a cleaved, N-terminal signal sequence.
3. Genetic organization
Substrates and components of Type 1 systems are encoded by gene
clusters found integrated into the chromosome or carried on plasmids.
These genes typically include the transport substrate, two export
functions and sometimes a gene that promotes the function of the
substrate. For example, the Hly operon (Fig. 1A) consists of the genes
hlyC, hlyA, and the exporter genes hlyB and hlyD. The additional gene
hlyC encodes an acyltransferase that acylates HlyA at two internal lysine
residues (Lys 540 and Lys 648) [9]. This lipidation is not essential for
secretion, but for hemolytic activity [10]. Without these two internal
acyl chains, the toxin is not capable of inducing pore formation in the
membrane of its host cell. A similar operon-like organization (Fig. 1B)
exists for genes encoding secreted lipases, proteases, adhesion proteins
or the iron-binding protein HasA. The gene encoding the OMP (TolC in
the case of the Hly system) is usually not found within the Hly operon.
However, TolC [11] is a multifunctional protein involved in many
important cellular processes [12], probably the most important one
being multidrug efﬂux. E. coli and other bacteria have a variety of
extrusion mechanisms to eliminate such xenobiotics. These include
ABC transporters, secondary transporters, the SMR (small multidrug
resistance) family and the RND (resistance, nodulation and cell
division) family [13]. The latter transporters provide drug resistance
through a tripartite efﬂux pump [14,15] that is composed of an RND
protein, an MFP and an OMP. The best-characterized example of this
type is the AcrB/AcrA/TolC system of E. coli, which has been studied
extensively at the functional and structural level [16]. The importanceFig. 1. Operon structures of selected T1SS. (A) chromosomal hemolysin, (B) Has and (C) SlaA/
in red, accessory genes like hlyC in orange, the gene for the transport substrates in dark blue,
blue if present in the operon. Regulatory elements such as fur are shown in black. The JUMPStar
hly-operons, represents the binding site of RfaH, are shown as gray and black boxes, respectiveof the AcrBA system is illustrated by the observation that deletion of
TolC renders bacteria sensitive to small amounts of detergents,
something they can cope with easily if the tripartite pump is properly
assembled.
Another Type I system, the sla-operon from S. marcescens, an
opportunistic pathogen, shows some important differences compared
to the hly-operon as seen in Fig. 1C. Exceptionally, the sla-operon also
includes the gene for the OMP (LipD). Moreover, in this case the
structural gene of the transported substrate slaA, encodes an S-layer
protein. More surprisingly, two more substrates utilize the Sla T1SS,
the lipase LipA and the protease PrtB [17]. However, these are both
encoded outside the operon.
4. Regulation
A survey of the literature on the regulation of expression and
secretion of substrates of T1SS revealed that to the best of our
knowledge only two different examples have been studied in any detail.
These are the Has system from S. marcescens and P. aeruginosa and
hemolysins from V. cholerae, N. meningitidis and in particular E. coli.
The operon structure for Has (heme acquisition system) is shown
schematically in Fig. 1B. For bacteria, heme is the major source of iron
[18]. After internalization heme is degraded and the released iron is
used for many key cellular processes. In principle, two modes of heme
uptake exist in bacteria. Class I systems utilize siderophore-dependent
uptake via speciﬁc surface receptors, activated through the
transenvelope, TonB–ExbB/ExbD complex. This transfers iron from the
exterior to the periplasm, where it traverses the inner membrane by
another mechanism [19,20]. The Has system is an example of class II
heme uptake [21]. This depends upon the extracellular heme binding
protein (HasA), which is secreted by a typical T1SS (Fig. 1). The secreted
HasA with bound heme, binds to an outer membrane receptor (HasR)
and the TonB dependent system, energized by ExbB/ExbD in the inner
membrane, enables heme transfer to the periplasm from where it
crosses the inner membrane [22]. As shown in Fig. 1B, upstream of the
hasA gene and hasR, the outermembrane receptor, is a fur (ferric uptake
regulator) box [23]. The furbox regulates expression of the downstream
genes. Fur is a dimeric DNA-repressor protein (encoded elsewhere in
the genome) that binds to the fur box in the Fe(II) bound state [24].
Under conditions of iron limitation, the Fur–Fe2+ complex dissociates,
then Fur is released from the fur box and transcription of the
downstream genes is initiated. When the cellular iron level increases,
binding of Fe2+ to Fur is promoted and the Fur–Fe2+ complex bindsLipA/PrtA system. The gene for the HasA surface receptor (and regulator), hasR is shown
the ABC transporter and the MFP in dark and light green, respectively, and the OMP light
t pause sequence, and the ops sequence, which is present in only 30% of the chromosomal
ly. Further details are given in the text.
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is more complicated, since HasR has a dual function, also playing a
role as a regulator of transcription of the has-operon. Studies by the
Wandersman group [25–27] demonstrated that the extracellular
binding of heme-loaded HasA to HasR, induces a transenvelope signal
cascade, which activates speciﬁc sigma and anti-sigma factors, encoded
by genes located close to the has-operon. These factors control hasR
expression and thus, heme availability is the master switch in the
regulation of transcription of the has-operon.
Early studies in the 1980s and 1990s in the Welch, Goebel, and
Hughes laboratories [28–32] indicated that one or more cis-acting,
non-coding regulatory sequences, at least several hundred base pairs
long and upstreamof the hlyC start codon, were required for expression
from both plasmid and chromosomal determinants that are present in
many uropathogenic E. coli (UPEC) strains. In contrast to the coding
sequences, these upstream regions were not highly conserved between
plasmid and chromosomal determinants (found in pathogenicity
islands). For example, an IS2 element just upstream of hlyC was found
only in plasmid determinants. Despite this, the basic mode of
regulation, involving a transcription elongation mechanism emanating
from a far distant upstream site, to overcome transcriptional polarity
(see below) appears common to both determinants. In fact, the most
detailed studies have involved hly-operons found in the chromosome
of UPEC strains and this is reﬂected in the literature reviewed below.
4.1. Molecular details of transcript elongation control by RfaH
RfaH, ﬁrst identiﬁed [33] as a positive regulator of the rfa-operon,
encoding components of LPS biosynthetic pathway, was also shown in
1992 to be required for transcription of the hly-operon [34]. The role
of RfaH was quickly shown to affect, in particular, the transcription of
the distally located exporter genes, hlyB,D [30,35,36]. Thus, the
expression of hlyC,A is uncoupled from the expression of hlyB,D in the
absence of RfaH. This led to the conclusion that RfaH, both in plasmid
and chromosomal operons, acts as an anti-termination factor,
speciﬁcally promoting elongation of transcripts from hlyC through
hylB and hlyD. This transcriptional polarity was thought likely to involve
a rho-independent terminator ﬁrst identiﬁed by Felmlee et al. [28]. This
is positioned in the intergenic space between hlyC and hlyB and
predicted to adopt a stem loop structure in the coding mRNA. In fact,
other studies led to the realization that the cis-acting, upstream
regulatory region, the RfaH protein, and the phenomenon of
transcriptional polarity, were all part of the same process. Thus, within
the large upstream non-coding region, two discrete motifs just
downstream of the hlyC promoter were identiﬁed as essential for high
level, RfaH dependent transcription, from the hlyC promoter. The ﬁrst
motif, identiﬁed originally by Hobbs and Reeves [37] is a 39 base pair
sequence shared by the non-coding regions of the hly and rfa-operons,
called JUMPstart (just upstream of many polysaccharide-associated
starts). Leeds and Welch [35], deleted this motif, which is more than
1 kbp away from the hlyC start codon, and this abolished RfaH
dependent transcription through hlyC. The authors proposed that RNA
polymerase paused at JUMPStart, suggesting an opportunity for RfaH
to bind to RNA polymerase. Bailey et al. [34,38], identiﬁed a second
conserved, 8 bp motif just downstream of JUMPstart, designated as ops
(operon polarity suppressor), also required for transcript elongation
by RfaH.
So how does RfaH promote anti-termination from a remote upstream
regulatory site? The laboratories of both Hughes and Koronakis, and that
of Welch, formulated the idea that RfaH is recruited to the RNA
polymerase complex at the ops and or JUMPstart sites. More recent
work now conﬁrms this, providing some surprising and exciting
molecular details that seem to supplymost of the answers. RfaH, although
acting highly selectively, is in fact a homologue of NusG, a general
transcription elongation factor that is recruited to RNA polymerase
complexes to suppress downstream pausing in many different operons[39]. Artsimovitch and Landick [39] examined in vitro and in vivo how
RfaH targets the ops-containing operons. They found that RNA
polymerase, initiating transcription from a promoter such as hlyC,
makes an early pause, likely at JUMPstart, which exposes the non-
coding strand of ops to which RfaH is able to bind. Apparently this leads
to binding of RfaH to the polymerase itself and the establishment of a
stable polymerase complex that increases the rate of the resulting
transcription as well as promoting long distance processivity and
suppression of pausing at various terminators. This is therefore clearly
consistent with the up to 10 kbp, RfaH dependent transcripts, found
associatedwith expression of the hly-determinants. Interestingly, a recent
study by Belogurov et al. [40] has conﬁrmed two binding sites in the N-
terminal domain of RfaH, a polar patch on one side, apparently interacting
with the ops single strand DNA, and on the other side, a hydrophobic
patch, which binds to the β-subunit of the polymerase.
4.2. Other possible regulatory mechanisms
Other indications of putative regulators of hly expression but
still lacking conﬁrmation, as physiologically relevant, include
post-transcriptional regulation and a possible form of temporal
regulation. Temporal regulation of HlyA secretion has been reported
by a number of groups, whereby secretion is apparently limited to a
relatively short period in the growth phase, triggered in early to mid-
exponential phase but then switched off in the transition to stationary
phase but before growth ceases [41]. This observation is not limited to
laboratory strains carrying recombinant plasmids but is also observed
with the UPEC strain, LE2001 [42]. Previous studies have demonstrated
the impossibility of generating even small amounts of either HlyB or
HlyD produced from a variety of promoters or in different growth
conditions. However, toxicity or instability of the overexpressed protein
could apparently be ruled out. In fact, Blight et al. [43] showed that
these constructs, while failing to produce proteins, in fact expressed
high levels of hlyBmRNA from the different promoters. Moreover, large
amounts of HlyB and HlyD fusions could indeed be obtained, when
coding sequences for hlyB and hlyD were placed downstream of
sequences for β-galactosidase and glutathione-S-transferase respectively
[43,44]. These and other results indicated that translation of the normal
transcript was inhibited by, for example, proximal mRNA 3D-structures,
which are rendered ineffective in the fusion to large upstreammessages.
Interestingly, in this context Landraud et al. [45] identiﬁed an additional
toxin gene encoded downstreamof hlyD inmanyUPECHly determinants
that is also transcribed from hlyC, dependent on RfaH. Curiously, this
toxin gene, cnf1, has its own, immediately upstream promoter. However,
translation of this resulting messenger is much reduced by a mechanism
involving mRNA folding that masks the ribosomal binding sequence. In
contrast, the authors report that hlyACBD transcripts from hlyC, which
proceed through cnf1, apparently results in ‘ironing out’ the inhibitory
mRNA folding, and translation of cnf1message is then much increased.
Reports of other factors affecting hly expression include roles for the
H-NS andHha global regulators of nucleoid organization [46], particularly
to repress expression at low temperature; an independent promoter just
upstream of hlyD; a requirement for the rare codon tRNA5leu (leuX) [47];
regulation by the two component signal transduction system MisR/MisS
inNeisseriameningitides [48];while expression of a Type 1 (Hly) secretion
system in Vibrio anguillarum, is positively regulated by hlyU [49]. In the
(enterohemorrhagic, EHEC strain of E. coli O157:H7) hemolysin
expression appears also to be inhibited by H-NS, but this effect is
antagonized by Dsr2, a small non-coding RNA [50], which interacts
directly with H-NS. In addition however, Dsr2 stimulates the synthesis
of the RpoS sigma factor, which is required for expression of this typical
hly-operon. Finally, an intriguing ﬁnding also indicated that in trans
over-expression of hlyA from a heterologous promoter, in the absence of
the export proteins, led to at least a three-fold reduction in hlyC expressed
from the wild-type promoter in the same cell. This suggested a possible
feed-back repression of hlyC by the non-transported HlyA [51].
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stress that results from laboratory strains in laboratory conditions give
only a limited view of the physiological nature of hly-regulation. In
particular, we presume that full expression of hly genes only occurs
during an infection. Does this involve a stochastic switch or a quorum
sensing mechanism regulating RfaH production in vivo or some other
limiting factor? Is expression limited in vivo to a sub-population of
cells? Finally, what is the functional signiﬁcance of transcriptional
polarity? As an option to attain hlyC, hlyA expression independently of
those for export functions, this does not seem to make much sense.
Transcript termination at hlyB therefore remains a puzzle. On the
other hand, as hinted at in [39] there could be an advantage in a factor
like RfaH stabilizing the polymerase complex, in order to ensure
coordinated expression and therefore utilization of all the products of
the very large hly-operon. Thus, the suggestion by Artsimovitch and
Landick [39] of localized cell factories, where closely associated nascent
polypeptides are assembled into multiple secretion machines, is very
attractive. Secretion initiated in such a localized environment, in
which a transport substrate such as HlyA is ﬁrst tethered (see below),
by the ABC protein and threaded into the transport channel as soon as
the C-terminal signal is released from the ribosome, would make sense.
5. Architecture
According to our deﬁnition, a T1SS is a complex of three membrane
proteins (ABC-transporter, MFP, OMP) that enables the transport of a
substrate (Fig. 2) to the exterior in one step across both lipid bilayers.
To ensure formation of a functional transporter all three proteins need
to assemble in a deﬁned order via molecular interactions. In this section
we shall have a closer look at the architecture of a Type 1 machine as
illustrated by the HlyA T1SS with amain focus on the proteins involved,
their order of assembly and interaction with HlyA.
5.1. TolC — the outer membrane protein
The outer membrane protein of the HlyA T1SS is TolC, although the
gene is not linked to thehly-operon [52]. The structure for TolCwas solved
in 2000 by Koronakis et al. [11] and revealed important information
regarding the transport mechanism. TolC forms homotrimers that make
up a 140 Å long channel protruding deep into the periplasm. This is
composed of a short β-barrel (outer membrane) and long, α-helical
(periplasmic) structure. The maximum width of the trimeric complex isFig. 2. Schematic summary of selected substrates of T1SS (not drawn to scale). The C-terminal
From top to bottom, hemophore HasA from S. marcescens, which does not contain any GG-repe
the lipase LipA from S. marcescens, which contains 13 GG-repeats and HlyA from E. coli cont
individual Uniprot entries (HasA, Q54450, PrtB, P16316, LipA, Q59933 and HlyA, P08715. The tw
by red arrows. The gray, vertical line in the schematic summary of HlyA denotes the N-termin40Å (internal diameter 20Å), narrowing to only 3.5Å at the periplasmic
end [11,53,54]. The latter is too small to enable passage of ions, and
certainly for folded proteins [55]. For opening of the channel, evidence
for an iris-like movement, rearranging the α-helices to widen the
periplasmic entrance to roughly 30 Å, suitable for passage of protein
secondary structures [11,56–58], has been obtained. Furthermore, the
large water ﬁlled cavity at the external exit of TolC may be suitable for
partial folding of the secreted substrates in a protected environment
[55,59].
5.2. HlyD — the membrane fusion protein
The large family of “membrane fusion proteins” was ﬁrst described
by Dinh et al. in 1994 [60], who pointed out some low level identity
with viral fusion proteins, hence the name, membrane fusion proteins
[54,60]. However, this is a misnomer since there is no evidence that
MFPs can literally cause membranes to fuse. The MFP of the HlyA T1SS
is HlyD [61]. So far no structural data for the approximately 53 kDa
HlyD or other MFPs of T1SS are available. However, analogous
structures are known for periplasmic proteins like MexA, which is
anchored by a lipid extension to the cytoplasmic membrane and
forms part of a drug efﬂux channel [62]. HlyD is located in the inner
membrane [62–64] and topological analyses predict a short 60 residue
N-terminal cytoplasmic region, a single membrane spanning α-helical
region and a periplasmic domain of α-helices, followed by a large β-
strand C-terminal domain [62–64]. HlyD appears to form trimers [54]
and hexamers [65] as a functional unit. As Lee et al. [65] pointed out, a
possible hexameric state would obviously solve the symmetry break
between TolC (trimer) and HlyB (dimer) and allow symmetric
interactions between the individual components, since the hexamer is
the least common multiple. Such a hexameric formation was recently
shown for the MFPs MexA [66], AcrA [67] and MtrC [68].
5.3. HlyB — the ABC transporter
ABC transporters constitute the largest family of membrane
transport proteins. They are ubiquitous, present in pro-, and eukaryotes
as well as archeae, and catalyze the vectorial transport of an enormous
range of substrates into or out of cells (e.g. ions, amino acids, antibiotics
or proteins) energized by ATP across biological membranes, even
against concentration gradients [69]. The energy required for this
process is achieved by ATP binding and/or hydrolysis by two ATPsecretion sequence is highlighted as a black box, the 6 GG-repeats as green vertical lines.
ats, themetalloprotease PrtB from Erwinia chrysanthemi, which contains three GG-repeats,
aining six strictly consensus GG-repeats. The number of GG-repeats was taken from the
o internal lysine residues (K564 and K690) that become acylated by HlyC are highlighted
us of C-terminal fragment of HlyA, HlyA1.
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are typically composed of two hydrophobic transmembrane domains
(TMDs) and two hydrophilic nucleotide binding domains (NBDs) [70].
The four domains can either be located on one polypeptide chain
(eukaryotes, full size transporter) or in separate polypeptides that
assemble to form a stable complex [70–72]. HlyB (approximately
66 kDa) is a so-called half-size transporter with one NBD and one
TMD in a single polypeptide. Two HlyB monomers then assemble
upon ATP binding to form a functional dimer, the active conformation
of HlyB [73–75]. In contrast to the NBDs, with several highly conserved
motifs, the TMDs of ABC transporters show little sequence conservation.
This is consistent with the capacity of these transporters to speciﬁcally
bind and transport a wide range of small molecule substrates, or, in
the case of Type 1 substrates like HlyA, the TMDs may actually form a
channel for extrusion of cognate polypeptides [76].
5.3.1. The alternating access model — does it apply to protein secretion?
The ABC transporter is central to all T1SS, since it provides energy for
translocation as well as forming speciﬁc interactions with the MFP and
the substrate. The conversion of chemical energy from ATP into
mechanical energy for physical translocation of the substrate across a
biological membrane is a central issue of ABC transporter research,
although much detail remains to be understood. However, it is beyond
the scope of this review to give a detailed update of the molecular
structure-function of ABC transporters. For further information the
reviews of Hanekop et al. and Biemans-Oldehinkel et al. are
recommended [77,78]. However, in brief, currently the “ATP switch
model” the “processive clamp model” and the “close contact” model
[79–81] provide the bestﬁt to the experimental data on ABC transporter
function, at least with regard to transport of small substrates like drug
molecules. Here, binding of ATP induces a switch of the ABC transporter
from the so-called inward facing to the outward-facing conformation. In
the case of an ABC exporter, a drug ﬁrst bound to the inwardly facing
membrane binding site, is transferred to an extracellular orientation,
which has a reduced substrate afﬁnity and the drug is therefore released
to the exterior. Hydrolysis of ATP resets the system, i.e. return of the
ATP-bound outward conformation to an inward facing conformation.
This scenario is in line with structural studies of ABC exporter and
importer systems for small molecules [76,82–84]. How relevant is this
model to the role of Type1 ABC proteins in translocating large unfolded
polypeptides? First it is important to note that while drug molecules
most likely access the ABC TMDs laterally from the bilayer, molecules
like HlyA must ﬁrst dock with the export proteins, approaching from
the cytoplasm. It is then generally agreed that the largely unfolded
Type 1 proteins are transported to the exterior through a continuous
transenvelope channel. If HlyB constitutes part of that channel it is
extremely difﬁcult to see how the alternating access model can apply
in this case.
5.4. Assembly of the HlyA T1SS
In the last decade, extensive experiments provided important
evidence on how the Type 1 translocator is assembled. Nevertheless,
the precise molecular mechanism is still not completely understood.
Early protein interaction experiments by Létoffé et al. [85] with PrtC
and HasA secretion employed co-puriﬁcation methods, and Thanabalu
et al. [54] working with HlyA, in cross linking studies, both indicated
that assembly was an ordered reaction. They could show that the ABC
and the MFP proteins interacted in the absence of the OMP and the
substrate molecule. In the presence of the substrate the OMP was
found in the complex. Both groups also detected an interaction between
the transport substrate and the ABC protein. Another study also showed
that HlyD was destabilized and degraded in the absence of HlyB and
TolC [45]. In addition, Balakrishnan et al. [86] demonstrated that the
short N-terminal cytoplasmic extension of HlyD was essential for the
interaction with HlyA and that the latter interaction was necessary forthe recruitment of TolC. Together, all these ﬁndings led to the following
model for the assembly of Type 1machines: HlyA recognizes HlyB prior
to HlyD recruitment or alternatively, HlyA recognizes the transient
HlyB/HlyD complex. In either case, binding of HlyA induces a
conformational or chemical change in HlyD, which triggers the “on
demand” recruitment of TolC [54,85]. This generalmodelwas supported
by several mutagenesis studies and different sub-domains involved in
these interactions were reported as discussed below.
5.5. Interactions and mutant studies involving HlyB
Benabdelhak et al. [87] identiﬁed in vitro a speciﬁc interaction
between puriﬁed protein fragments constituting the C-terminal
secretion signal of HlyA and the NBD of HlyB, with a measured KD of
4 μM. Moreover, addition of ATP displaced the signal sequence from
HlyB, suggesting that this may play a role in vivo in the initiation of
secretion. On the other hand, evidence that the HlyA secretion signal
has a docking site in the HlyB-TMDs was claimed by Zhang et al. [88].
This was based on TMD mutations, which suppressed the “secretion”
defect caused by deleting 29 residues from the C-terminus of HlyA,
rather than an initial docking site. However, the readout for secretion
in this study was HlyA activity and recently Jumpertz et al. [89] showed
that deletion of several residues from the C-terminal of HlyA did not
disrupt secretion but affected protein folding and therefore hemolytic
activity. Thus, the Zhang et al. supressors may indicate changes in the
translocation pathway formed by the TMDs. Other studies of HlyB
[90], included identiﬁcation of a functional hotspot in the predicted
small periplasmic loop of approximately 12 residues between
transmembrane helices 5 and 6. Four out of ﬁve residues targeted for
mutagenesis gave a marked secretion defect. This loop is better
conserved than other regions of the TMDs and could represent a point
of interaction with MFPs or its own NBD. Sugamata and Shiba [91]
identiﬁed two point mutations in HlyB that drastically (up to 27x)
increased the secretion of a HlyA fusion protein. One mutation is
localized just upstream of the NBD and is thought to be important for
ATP binding [73]. A mutation reducing the ATPase activity of HlyB,
which appeared to result in the exciting discovery by Thanabalu et al.
[54] that translocation of HlyA stalled in the channel, was unfortunately
never followed up.
5.6. Mutant studies and the role of HlyD
Balakrishnan et al. [86] demonstrated a speciﬁc interaction of HlyA
with the cytoplasmic domain of HlyD necessary for TolC recruitment,
while a mutational analysis by Schlor et al. [92] ﬁrst indicated an
interaction between HlyB and HlyD, conﬁrmed later by other groups.
It has been generally assumed therefore that HlyD forms in some way
part of the transenvelope structure. But what is the precise structural
role of HlyD — to promote contact between HlyB and TolC or to form
part of the channel itself? In fact, several genetic studies indicate that
HlyD does constitute part of the channel. Thus, Schülein et al. [93],
showed that substitution of the (periplasmic) C-terminal arginine of
HlyD leads to increased amounts of cell-associated HlyA, suggesting
that movement through, or release from, the translocator is perturbed.
Pimenta et al. [44,94] described mutations in the periplasmic domain
of HlyD, which led to secretion of an inactive form of HlyA that could
be “reactivated” by refolding following denaturation. A more recent
approach to identify functionally important HlyD amino acids was
carried out by Lee et al. [65]. They identiﬁed a conserved motif (RLT)
in themiddle of the periplasmic domain that recognizes TolC.Mutations
even in one amino acid abolished TolC recruitment and HlyA secretion.
Finally, HlyD has a TolC-homologous domain that is suspected to form
β-strands, which could interact with similar TolC domains to widen
the TolC pore and enable HlyA transport [92,93]. All these results
underline the importance of HlyD in the T1SS, indicating that it forms
part of the physical transport channel, including an interaction with
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membranes to allow a direct HlyB-TolC interaction
6. The substrate(s) and the initial steps of secretion
6.1. The secretion signal
Table 1 summarizes a list of examples of Type 1 secreted substrates.
This attempts to cover the most important functions that have been
attributed to proteins secreted by T1SS. All these proteins (Fig. 2)
contain a C-terminal secretion signal and comparative analysis of
secretion sequences revealed at least two major subfamilies, the non-
RTX proteases (PrtB) and the RTX-proteins (HlyA) [95]. However, one
has to stress that a certain overlap exists. The HlyA machinery, for
example, primarily secretes RTX-proteins, but low levels of secretion
of the heterologous PrtB family by HlyB and HlyD, have been reported.
Type 1 substrates of T1SS can also be divided into proteins containing
an RTX domain and those where the RTX-domain is absent (see
below). Nevertheless, as described below, even within a subfamily
there is no obviously universal secretion sequence.
In the case of HlyA, the secretion sequence (Fig. 3) was mapped to
the last 48 to 60 C-terminal amino acids [96–99]. This stretch of
amino acids can be further subdivided into a region containing two
clusters of charged amino acids (976–996), uncharged amino acids
(997–1009), hydroxylated amino acids (1017–1024) and a so called
aspartate box (amino acids 994–1009) (Fig. 3). Sequence analysis
furthermore indicated that the charged and uncharged section might
form an amphipathic helix. In contrast, X-ray crystal structures of
members of the PrtB family show that the corresponding region of the
secretion signal preferentially forms β-strands. Mutational studies
furthermore demonstrated an extreme level of redundancy with
respect to the primary structure of the HlyA secretion sequence. Out
of the approximately 50 amino acids only a handful (Fig. 3), ﬁve to be
precise, displayed a signiﬁcant reduction (i.e. more than 50%) in the
secretion levels of HlyA, and a much greater reduction when the
mutations were combined. [99–101]. A similar degree of redundancy
at the level of the primary structure of the signal sequence was found
for PrtB and the S-protein of C. crescentus. These results pointed towards
a possible structural motif within the secretion sequence that is
recognized by one or both export proteins. Subsequent CD and NMR
studies on the isolated secretion sequence provided no hints of any
secondary structure. However, after the addition of triﬂuoroethanol aTable 1
Overview of substrates of T1SS. The asterisk indicates that a crystal structure is available
for this particular protein. Plas: plasmid, Chrom: chromosomal.
Function Examples Amino
acids
Organism Architecture of
the T1SS
Heme-binding HasA* 188 S. marcescens HasD/HasE/HasF
219 P. aeruginosa HasD/HasE/HasF
206 P. ﬂuorescens HasD/HasE/HasF
RTX toxin HlyA 1024 E. coli HlyB/HlyD/TolC
CyaA 1706 Bordetella pertussis CyaB/CyaD/CyaE
RtxA 4558 Vibrio cholerae RtxB/RtxD/unknown
FrpA 1115 Neisseria
meningitidis
unknown
Protease PrtA 472 S. marcescens LipB/LipC/LipD
AprA* 477 P. ﬂuorescens AprD/AprE/AprF
479 P. aeruginosa AprD/AprE/AprF
PrtB* 481 Erwinia
chrysanthemi
PrtD/PrtE/PrtF
Lipase LipA* 613 S. marcescens LipB/LipC/LipD
TliA 476 P. ﬂuorescens TliDEF/unknown/
unknown
Adhesin SiiE* 595 S. enterica unknown
LapA 888 P. ﬂuorescens unknown
S-layer protein RsaA 1026 Caulobacter
crescentus
RsaD/RsaE/RsaF
SlaA 259 S. marcescens LipB/LipC/LipDhelix loop helix motif could be identiﬁed [102,103]. One has to stress
here that triﬂuoroethanol is the strongest helix-promoting agent
known today and the results should be interpretedwith the appropriate
caution. In summary, the exact mode of recognition between the
transporter and the secretion signal is still unclear. Whether the
potential amphipathic helix interacts with the lipid bilayer and or
HlyB, whether a secondary structural motif is recognized or whether
the ﬁve critical amino acids identiﬁed, act as a recognition platform
for the translocator, is currently unknown. Finally, we recently showed
that the last 6 C-terminal residues of the secretion signal appear to play
a dual function, being also involved in someway in catalyzing folding of
HlyA [104].
6.2. The RTX, Ca2+ binding motifs
In addition to the secretion sequence, T1SS substrates contain a so-
called RTX domain. Nonapeptide repeats rich in glycine and aspartate
residues, the so-called GG-repeats, characterize this domain, which
has the consensus sequence GGxGxDxUx (x: any amino acid and U:
large or hydrophobic amino acid) [105]. Folding experiments in vitro
demonstrated that these GG-repeats trigger folding of the substrate by
binding Ca2+ ions in a 1: 1 stoichiometry with an afﬁnity of
approximately 100 μM. The cytosolic concentration of Ca2+ in E. coli
and other Gram-negative bacteria (300 nM for E. coli) is well below
the dissociation constant (KD) of the Ca2+/GG-repeat complex
compared to up to 10mM in the extracellular space [106]. Thus, folding
of HlyA and other substrates of T1SS containing GG-repeats would only
start when the polypeptide reaches the mM Ca2+ concentrations at the
cell surface. The importance of these GG-repeats is highlighted in the
crystal structures of Type 1 substrates, which have been reported so
far [104,107–111]. First, the HasA protein, which has no RTX repeats.
When the structure was determined in the apo state (not shown) and
the heme-bound state (Fig. 4) it was found to have one Ca2+ ion located
next to the prosthetic group. Therefore, while themechanism of folding
of HasA remains a mystery it is unlikely to involve Ca2+ ions. In the
recently reported crystal structure of a fragment of the RTX protein,
SiiE [104], a giant nonﬁmbrial adhesion protein from Salmonella enterica
(5590 amino acids), eight Ca2+ ions were identiﬁed. They are, as
expected, bound to the RTX-GG-repeats forcing these motifs into a
characteristic β-roll conformation. Similarly, for the alkaline protease
from P. aeruginosa (Fig. 4), LipA, a lipase from S. marcescens (Fig. 4) or
serralysin, the major metalloprotease from S. marcescens (not shown),
Ca2+ is tightly bound to the RTX-GG-repeats. In the structure of alkaline
protease from P. aeruginosa, eight Ca2+ ions were unambiguously
identiﬁed, which induce the formation of a “parallel beta roll motif”, a
structural element so far unique to the substrates of T1SS. These
structures, in combination with the available folding data for HlyA or
other RTX substrates, send a clear message — no folding and
consequently no three-dimensional structure in the absence of Ca2+.
In other words, HlyA does not fold and does not adopt its native
structure on a biological time scale if Ca2+ ions are not present or an
extremely low level as in the cytosol. Conversely, extracellular or
surface calcium can be expected to promote folding of HlyA as it
emerges from the TolC channel, with the potential to provide energy
for extrusion of HlyA.
6.3. ABC proteins tether Type 1 substrates before the secretion signal is
synthesized
Other lines of evidence including the apparently restrictive internal
diameter of the TolC structure [12], also strongly supports the idea
that T1SS substrates are unfolded during translocation. In this
laboratory, studies employing hybrid proteins of MBP (maltose binding
protein) or subsequently IFAB (internal fatty acid binding protein) fused
to the C-terminal fragment of HlyA (HlyA1, containing three RTX
repeats) demonstrated that the folding rate of the passenger dictated
Fig. 3. Primary structure of the extreme C-terminus of plasmid-encodedHlyA (Uniprot entry P08715, residues 971–1024). The position of the putative amphipathic helix and the aspartate
box are indicated. The aspartate box is a stretch of small amino acids enriched in alanine and serine ﬂanked by aspartate residues. This sort of conservation was derived from sequence
comparison with other HlyA-like proteins. Furthermore, sequence alignments indicated the presence of stretches of charged, uncharged and hydroxylated amino acids. The cluster of
hydroxylated amino acids is apparently speciﬁc for the secretion sequence of the HlyA subfamily. The blue amino acids highlighted in the lower panel are those residues that were
determined as essential for secretion in saturation mutagenesis experiments employing randomized primers. Blue arrows emphasize their positions.
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folding rate but not the un-folding rate was slowed down, we obtained
a strict correlation between folding rate and secretion efﬁciency. All
these results raise an interesting question: how do these substrates,
some extremely large, remain unfolded and in a secretion competent
state in the cytosol of Gram-negative bacteria, without being
proteolytically digested or simply aggregated? A possible answer to
this question was found in 2012 by Lecher et al. [112] who showed
that the N-terminal domain of HlyB is effectively a dead C39 peptidase
that binds and tethers HlyA prior to transport. A detailed description
of this is now presented in the next section.Fig. 4. Crystal structures of HasA from S. marcescens (A, pdb entry 1B2V), SiiE from S. enterica (
P. aeruginosa (D and E, pdb entry 1KAP). Individual structures are shown in cartoon representat
RTXmotif coordinating two Ca2+ ions of the alkaline protease is enlarged in (D). The identity o
black lines connecting panel (D) and (E). Dashed black lines in (D) highlight the interactions bAs indicated above the secretion signal necessary for translocation
across two membranes is located in the extreme C terminus of Type 1
proteins (Fig. 2). An extreme example— LapA, a large adhesion protein
from Pseudomonas ﬂuorescens WSC365, is composed of 8682 amino
acids (molecular weight of approximately 900 kDa) and more than
8500 amino acids have to be synthesized before the appearance of the
secretion sequence, i.e. the information that targets this protein to its
cognate secretion machinery.
Elegant work byWandersman and colleagues demonstrated a strict
dependence for secretion of the iron-scavenger HasA on the antifolding
activity of SecB [113]. Indeed, slow folding mutants of HasA did notB, pdb entry 2YN5), LipA from S. enterica (C, pdb entry 2QUA) and alkaline protease from
ion, Ca2+ ions as green spheres and the cofactor heme of HasA in stick representation. The
f the two Ca2+ ions within the alkaline protease structure is indicated by the two dashed,
etween the Ca2+ ions and the RTX motif (GG-repeats).
1636 S. Thomas et al. / Biochimica et Biophysica Acta 1843 (2014) 1629–1641require SecB. These results provide evidence that secretion of the
non-RTX-HasA also occurs in a non-native conformation lacking
any tertiary structure. Notably, however, SecB dependence has not
been demonstrated for any other Type 1 system, including the HlyA
T1SS. This leads again to the surprising conclusion that substrates
remain unfolded in the cytosol until secretion is initiated. Thus,
how such polypeptides survive becomes even more intriguing.
Despite the enormous variation in the nature and size of ABC-
transport substrates, all ABC transporters possess a canonical architecture.
Two transmembrane domains (TMD) and two nucleotide-binding
domains (NBD) form the functional unit, which can be arranged in any
possible combination [114]. Despite this variability, the NBDs always
contain the conserved sequence motifs of ABC transporters and the
TMDs almost invariably appear to provide the means of translocation.
However, some ABC proteins contain additional N- and C-terminal
domains appropriate to their speciﬁc function. HlyB, the ABC transporter
of theHlyA system(but not theHasDandPrtDhomologues), possesses an
N-terminal extension of approximately 130 amino acids. Sequence
comparison revealed that this extension bears the signature sequence of
C39 peptidases. These are thiol-peptidases containing a catalytic triad
(Cys-His-Asp) that promotes cleavage C-terminal to a GG sequence
required, for example, for bacteriocin export [115]. In the latter, the C39
peptidase is fused N-terminally to an ABC transporter and cleaves
the bacteriocin leader peptide. The cleavage site is located at the
N-terminus of the precursor bacteriocin, following a conserved GG
sequence and is cleaved prior to or during translocation across the cell
envelope of Gram-positive bacteria. Notably, in HlyB, the catalytically
relevant Cys is missing, resulting in the C39-like domain (CLD) forming
an enzymatically inactive N-terminal appendix. In our previous
functional studies, the CLD was shown to bind exclusively to unfolded
HlyA or the C-terminal 240 amino acid residues of HlyA (HlyA1, see
Fig. 2), which contain three of the consensus RTX-repeats. Importantly,
the CLD still binds to HlyA1 lacking the secretion sequence [112].
This functional analysis was also complemented by NMR studies of
the CLD of HlyB that revealed not only the structure but also the HlyA-
binding site within the isolated CLD [112]. First, the results showed
that the CLD has a high overall structural similarity to active C39
peptidase [116]. However, the binding site of the CLD for the HlyA1
fragment was not located at the reported binding site for GG-residues
in C39 peptidases, but on the opposite side of the protein. This therefore
raises the possibility that CLD, a degenerated C39 peptidase, no longer
recognizes GG-repeats but recognizes some other motif in HlyA1,
proximal to the secretion signal. Importantly, mutagenesis studies
targeting the HlyA1 binding site demonstrated a clear correlation
between substrate binding by the CLD and the observed HlyA secretion
levels. This indicated that the CLD is not only capable of binding
unfolded HlyA, but in consequence acts as a binding platform that
sequesters the substrate, keeping it in an appropriate state for
translocation and inaccessible to proteases until the secretion signal
engages the transporter [112].
HasD, the ABC transporter of the HasA T1SS from S. marcescens, is
in contrast to HlyB a simpler, more typical ABC transporter, i. e. it
contains no CLD or any other N-terminal extension. Nevertheless,
Wandersman and coworkers identiﬁed so-called “primary interaction
sites” that are spread throughout the sequence of HasA and apparently
act independently of the C-terminal secretion sequence [25,117]. These
interaction sites (whose sequence is not yet established), if deleted,
reduced HasA secretion. Thus, the secretion of HlyA and HasA,
independently of the secretion signal, may involve a speciﬁc step
to tether, albeit by different mechanisms, the substrate to the ABC
transporter, prior to translocation. Surprisingly, in the same studies
Wandersman and coworkers [25,117] also demonstrated that the
C-terminal secretion sequence is required to disassemble the
translocation machinery, i. e. the ﬁnal step in HasA secretion. Again,
this appears to be fundamentally different from that of the
HlyA system. Thus, Koronakis and coworkers demonstrated thatthe C-terminal secretion signal is actually important for the initial
assembly of the secretion machinery [54]. Importantly, arising from
these results, which indicate an additional interaction between
both HasA and HlyA with their respective ABC transporter,
emphasize that the notion that “the secretion sequence is necessary
and sufﬁcient for substrate translocation” may now require some
modiﬁcation. At least in the case of HlyA, recognition of the HlyB
CLD may involve sequences upstream of the secretion signal, which
likely result in a particular, pre-translocation state, prior to the
initiation of secretion.
7. Interaction of HlyA with its cellular target membrane
Over the last 40years, investigations have been carried out regarding
the interaction of HlyA and other RTX toxins with natural or artiﬁcial
cell membranes. Yet the exact mode of action is still not clearly
understood and many aspects have to be considered. Here we
summarize some major factors that affect the activity of HlyA.
7.1. Cell type
RTX toxins have been commonly divided, perhaps arbitrarily, into
two groups regarding their range of host cell speciﬁcity, namely
hemolysins (broad target cell range) and the more speciﬁc leukotoxins.
The former are named after the fact that erythrocytes are highly
susceptible to this class of toxins and cell lysis can be easily monitored
by release of hemoglobin on blood plates. HlyA, as the name indicates,
belongs to the hemolysin group andmany cell types have been reported
to be sensitive to HlyA, such as monocytes [118,119], lymphocytes
[119], neutrophils [120,121], and in addition, endothelial [122] and
renal epithelial cells [123], ﬁbroblasts [124,125] and of course
erythrocytes [126–128]. These early studies concluded that HlyA was
toxic as a result of pore formation [129]. However, studies in the last
few years indicate that ﬁrst, pore formation is complex and second
there may be different pathways of cell killing by HlyA, as discussed
below.
7.2. Steps in the formation of HlyA pores
There are several predicted pathways for HlyA interaction with cell
membranes, which can be roughly grouped into (i) receptor free pore
formation by HlyA molecules, (ii) receptor dependent pore formation
and (iii) action involving HlyA in an association with outer membrane
vesicles.
(i) The broad host spectrum and themany different cell types lysed by
HlyA led to the assumption that cell death was induced by membrane
insertion to form pores, consequent osmotic shock, cell swelling and
ﬁnally cell lysis [129–131]. This was demonstrated by channel formation
monitored in planarmembranes and unilamellar vesicles, model systems
containing pure lipids, and lacking putative protein receptors [132,133].
More recent proponents of this receptor-independent mode of action
are Valeva et al., who observed a nonsaturable binding to rabbit
erythrocytes that excluded a speciﬁc receptor interaction [134]. In
addition, earlier studies led to the suggestion of a multistep process for
pore formation, reversible adsorption of the toxin to the membrane
followed by nonreversible insertion [135–137].
There have also been some investigations of the inﬂuence of calcium
on HlyA action, but with contradictory results. Ostolaza and Goñi [137]
stated that in the presence or absence of Ca2+, HlyA binds equally well
to lipid bilayers and liposomes (see also [138]). In contrast, for example,
Döbereiner et al. [139] conﬁrmed earlier results that calcium is
important for cell-surface recognition, but is not required for pore
formation. Inconsistent ﬁndings have also been reported for the
necessity of acylation of HlyA for membrane binding. Some authors
found no binding of non-acylated HlyA to erythrocytes [140,141],
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without acylation.
After adsorption to the cell membrane a change in HlyA occurs that
leads to insertion. This form of the protein can only be extracted from
the membranes by detergents [130,143]. The insertion step is followed
by cell lysis, a process requiring Ca2+ [137–139,144] and the acylation
sites [142,145], with partially acylated HlyA having a reduced lytic
activity [134]. Finally, in contrast to the initial binding of HlyA to the
membrane, the physical characteristics of the bilayer are highly critical
for insertion of the toxin [135]. Although it is widely acknowledged
that HlyA forms some kind of pore in the membrane that leads to an
inﬂux of calcium into the cells, precise details of the interaction of
HlyA with membranes are still controversial.
(ii) Receptor mediated cell membrane interactions for at least some
RTX toxins were ﬁrst postulated in order to explain the narrow cell
target range of the leukotoxins. However, Lally et al. [146] suggested
that HlyAmight also require a speciﬁc receptor since antibodies against
potential receptors such as the β2 integrins were found to prevent cell
lysis by HlyA. This would also explain why Simpson et al. [147] failed
to see HlyA induced lysis on K562 cells since these do not express β2
integrins. Recently, Morova et al. [148] described in detail such a
receptor-dependent mechanism for the adenylate cyclase toxin CyaA
from Bordetella pertussis. They showed that CyaA is able to recognize
the N-linked oligosaccharides of its cognate β2 integrin (αM or CD11b)
receptors and that loss of receptor glycosylation resulted in loss of
CyaA activity. While for CyaA it is proposed that binding to the β2
receptor triggers Ca2+ induced endocytosis of CyaA and thus protects
the cells from the immune system, such a machinery cannot be
envisaged for HlyA, since the cognate β2 integrin LFA-1 is not
internalized [149]. Instead, it is assumed that HlyA receptor binding
leads to the destruction of host immune cells, via activation of signaling
pathways due to calcium inﬂux generated by the resulting HlyA pores
[146].
A speciﬁc role for β2 integrin mediated interaction of RTX toxins
with erythrocytes was also investigated. Erythrocytes lack β2 receptors
and therefore the necessary glycosylation sites, however they have
other proteins that can function as binding partners such as glycophorin
for HlyA or gangliosides for CyaA [148,150]. This could explain the lack
of speciﬁcity in erythrocyte lysis observed with RTX toxins as well as
differences between erythrocytes from various organisms, for example,
rabbit erythrocytes lack glycophorin [134,151–153]. Finally, while very
likely dedicated receptors play a critical role in HlyA action in some
contexts, unfortunately little appears to be known regarding how
these receptors ultimately affect HlyA activity.
(iii) A potential thirdmode interaction of HlyAwith the host appears
to involve its associationwith outermembrane vesicles (OMV) from the
producing bacteria. The production of OMVs is common for Gram-
negative bacteria [154] and in 2003 Wai et al. showed that OMV
formation is essential for the activation of ClyA by altering the redox
status of the cytolysin [155]. Recently, Balsalobre et al. [156] showed
that HlyA associated with OMVs can account for up to 66% of the HlyA
protein population, independently of HlyA acylation. Furthermore, the
embedded protein was as active as the secreted HlyA and the vesicles
were highly resistant to urea treatment. How this form of HlyA is
delivered to the eukaryotic cell is currently unknown but some
experiments indicate that this involves endocytosis ([157], see also
[158]). Such ﬁndings also remind us that in experiments involving the
use of “puriﬁed” HlyA, this is likely to be contaminated with LPS,
which may markedly contribute to the outcome either by direct
potentiation of HlyA action in some way or independently in its own
right.
7.3. Pore formation requires oligomerization?
The size of the actual HlyA pore has also been and remains an
intriguing question. Different osmotic protection experiments wereperformed that predicted a pore size with a 1–2 nm diameter
[130,159–162]. However, Moayeri and Welch [163] pointed out that
temperature as well as time and toxin concentration play a crucial role
in pore formation. Moreover, the observed increasing pore sizes that
accompany treatment with HlyA, over time, led to the suggestion that
like complement, HlyA may have detergent-like properties. Indeed,
Ostolaza et al. [133] described a detergent-like function for HlyA at
high concentrations.
Whether pore formation requires oligomerization of HlyA is still
controversial. Several early studies indicated that one HlyA molecule is
sufﬁcient to trigger cell lysis, supporting the so-called “single-hit”
model for HlyA action [162,164,165]. On the other hand, Benz et al.
[166] reported that a small change in protein concentration had a
large effect on membrane conductance, while Ludwig et al. [167]
inferred that oligomerization occurred, since they achieved successful
reconstitution of hemolytic activity by co-expression of non-lytic HlyA
mutants. Bakás et al. found evidence of a cooperative process for HlyA
insertion into the target cell [135]. Some recent ﬁndings also provided
more direct evidence for multimerization by FRET transfer from labeled
to non-labeled HlyA molecules in treated membranes [145].
Nevertheless, no multimeric HlyA has been isolated so far.
7.4. HlyA domains that may play a role in pore formation
Several deletion and substitution mutations have been made in
order to identify HlyA domains, important for pore formation.
Cortajarena et al. [168] identiﬁed a highly conserved C-terminal (aa
914–936) sequence as a putative glycophorin binding site, required
for HlyA docking to the target cell (see also [100,169]). Ludwig et al.
showed that deletion of the predictedN-terminal,α-helical amphiphilic
region, improved pore stability and increased activity [170]. Sánchez-
Magraner et al. [153] showed that the RTX domain (towards the C-
terminus) was involved in the adsorption of HlyA, while the N-
terminal helical domain was necessary for membrane insertion of the
toxin. Finally, the acylation of K564 and K690 seems to have a major
inﬂuence on the overall folding of the protein, leading to an active
conformation [136,138,142,171]. In addition to all the above factors
that can affect HlyA activity it cannot be excluded that toxin
concentration is also important. This could, for example, inﬂuence
HlyA mediated receptor clustering at the cell surface of the host cell.
Additionally, speciﬁc receptor recognition might occur at low protein
concentrations, while pore formation is favored only at higher
concentrations [10,172].
7.5. Induction of signal cascades and channel activation upon pore
formation: mechanism of cell killing
In healthy cells, calcium levels are strictly regulated as they
modulate important signaling pathways, which in turn control many
cellular processes [173,174]. Disturbance of the host cell calcium levels
is therefore a common mechanism used by pathogens to manipulate
host cell properties including cell killing [175].
The normal intracellular free calcium level for sheep erythrocytes is
30 μM [176], whereas the calcium level required for full extracellular
HlyA activity is from 100 μM up to 20mM [165,177]. These differential
Ca2+ levels lead to an inﬂux of Ca2+ through the HlyA generated pore,
whether receptor mediated or not. This increase in free intracellular
Ca2+ can cause many, potentially lethal effects, for example,
rearrangements of the cytoskeleton [178] or degradation through
activation of the host serine protease mesotrypsin [179], of the
cytoskeletal scaffolding protein paxillin, and also NFκB, which is
responsible for induction of proinﬂammatory pathways. Other Ca2+
induced effects have been observed by Bhakdi et al. [118], including
depletion of cellular ATP, secretion of IL-1β and stimulation of
arachodonate metabolism, leading to apoptosis. HlyA action was also
associated with activation of P2X cation channels in mammalian
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known to be pro-apoptotic [181,182]. Clearly, the precise mechanism
of killing of target host cells by HlyA created pores is therefore complex
and still controversial and the reader is referred to a recent more
comprehensive, review [179].
8. Perspectives
Although many discoveries have been made in recent years
regarding the Hly, Has and many other T1SS, there are still some
mysteries that await a solution. These include not only the absence of
three-dimensional structures of HlyA and the full-length exporter
components of any of theType1 systems, but also the absence of an
in vitro reconstituted system for analysis. It is therefore obvious that
we need further molecular knowledge to ﬁnally understand the
coordination of this “simple” but highly effective bacterial secretion
system in space and time.
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